Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Elevat3 Capital is the venture capital arm of Christian Angermayer and his family office, Apeiron Investment Group. The organization manages over $250 million in assets and focuses on high-growth technology companies primarily in Europe, while also selectively pursuing opportunities in North America and Asia. Elevat3 Capital aims to add value beyond capital by influencing key factors that can enhance the valuation of its portfolio companies.
Elevat3 Capital invests in industries undergoing significant transformation, including Life Sciences, FinTech & Crypto, Future Tech, and the food industry. The firm typically leads or co-leads investments with ticket sizes ranging from $5 million to $20 million. Their investment strategy emphasizes high-growth opportunities that leverage innovative technologies, particularly in decentralized finance, real estate, food production, and health improvement.
Elevat3 Capital's portfolio includes over 100 high-growth tech companies. Notable portfolio companies include: **AmyriAD Therapeutics BV**: A biotech company focused on developing advanced treatments for Alzheimer's Disease, currently in Phase 3 clinical trials. **Formo**: A food biotech company creating sustainable dairy products using precision fermentation. **GROPYUS**: A PropTech company that digitalizes the housing market, offering affordable and sustainable living solutions. **Neodigital Versicherung AG**: A digital insurer providing comprehensive digitalization for B2B insurance services. **Periskop Partners**: A real estate investment platform focused on sustainable and impact-oriented projects across Europe. **Tiakis Biotech AG**: A biotech firm developing therapeutic solutions for high unmet medical needs, including treatments for postoperative complications and COVID-19.
To approach Elevat3 Capital, founders should prepare a compelling pitch that highlights innovative technologies and growth potential in sectors like biotech and fintech. Interested parties can submit their pitches through the firm's website at elevat3.vc or contact them via email at info@elevat3.vc.
Elevat3 Capital invests in Seed, Series A, Series B, and Growth Equity stages.
You can pitch Elevat3 Capital through their website at elevat3.vc or via email at info@elevat3.vc.
Elevat3 Capital focuses on biotech, healthcare, fintech, food-agtech, and proptech sectors.
The firm typically invests between $5 million and $20 million.
Elevat3 Capital primarily invests in Europe, with selective opportunities in North America and Asia.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.